Drug Profile
Aciclovir elaidate
Alternative Names: P 4010Latest Information Update: 30 Aug 2002
Price :
$50
*
At a glance
- Originator Norsk Hydro
- Developer Nonindustrial source
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Herpes simplex virus infections
Most Recent Events
- 30 Jul 1999 New profile
- 30 Jul 1999 Preclinical development for Herpes simplex virus infections in United Kingdom (Unknown route)